Lilly to build $2.5 billion diabetes drug plant in Germany
By Klaus Lauer and Ludwig Burger Eli Lilly will build its first plant in Germany for 2.3 billion
1970-01-01 08:00
Lilly extends tender offer to acquire Point Biopharma to Dec 1
Eli Lilly said on Friday it was extending the deadline for its tender offer for Point Biopharma shares
1970-01-01 08:00
Eli Lilly: still seeking UK approval on pen for weight-loss drug
By Maggie Fick and Ludwig Burger LONDON Eli Lilly on Thursday said it has not yet gained approval
1970-01-01 08:00
Eli Lilly to buy cancer-focused Point Biopharma for $1.4 billion
(Reuters) -Eli Lilly and Co will buy cancer therapy developer Point Biopharma Global for $1.4 billion, the companies said on
1970-01-01 08:00
Eli Lilly settles whistleblower lawsuit over manufacturing problems
By Dan Levine and Marisa Taylor Eli Lilly and Co and a former employee agreed to settle a
1970-01-01 08:00
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
By Blake Brittain Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5
1970-01-01 08:00
Eli Lilly sues over US sales of bogus Mounjaro for weight loss
By Patrick Wingrove Eli Lilly on Tuesday said it was suing 10 U.S. medical spas, wellness centers and
1970-01-01 08:00
Nimród Antal on directing Liam Neeson's movie Retribution: 'It was a challenge worth accepting!'
Nimród Antal thought ‘Retribution’ was a “challenge worth accepting" and explains why he wanted to work with Hollywood star Liam Neeson on the project.
1970-01-01 08:00
Lilly's obesity drug leads to about 26% weight loss in new studies
By Bhanvi Satija and Leroy Leo (Reuters) -Eli Lilly said on Thursday its experimental obesity drug helped patients reduce 26.6%
1970-01-01 08:00
Lilly drug slows Alzheimer's by 60% for mildly impaired patients in trial
By Deena Beasley (Reuters) -Eli Lilly's experimental drug donanemab slowed the progression of Alzheimer's by 60% for patients in the
1970-01-01 08:00
Uninsured US patients pay up to $330 for Eli Lilly’s $25 insulin, Senator Warren says
By Patrick Wingrove Americans without health insurance pay an average of $98 for Eli Lilly’s generic insulin despite
1970-01-01 08:00
Experimental Lilly pill, Mounjaro both lead to 15% weight loss in clinical trials
By Deena Beasley (Reuters) -In a mid-stage trial, the highest dose of Eli Lilly's experimental pill orforglipron led to 14.7%
1970-01-01 08:00